Heather Davis
Executive Director
Pfizer Global R&D, Vaccines Research, Site Head,
Ottawa Laboratories
Ottawa, ON

Dr. Davis serves as Executive Director, Vaccine Research Unit, as well as Site Head for Pfizer’s Ottawa location. Dr. Davis was a scientific co-founder of Coley (1996) and served as Managing Director of Canadian operations and Senior Vice President, Pharmacology R&D until Coley was acquired by Pfizer in 2008. She previously held academic positions at University of Ottawa (Professor) and McGill University, Montreal and carried out pioneer work with DNA vaccines and CpG adjuvants. Dr. Davis holds a PhD in Anatomy from the University of Western Ontario.

Back